Citations (119)
Keep up to date with the latest research on this topic with citation updates for this article.
Read on this site (11)
Kristine Broglio, Lale Kostakoglu, Carol Ward, Federico Mattiello, Denis Sahin, Tina Nielsen, Anna McGlothlin, Corrine F. Elliott, Thomas Witzig, Laurie H. Sehn, Marek Trnĕný, Umberto Vitolo, Maurizio Martelli, Margaret Foster, Barbara Wendelberger, Grzegorz Nowakowski & Donald A. Berry. (2022) PET-CR as a potential surrogate endpoint in untreated DLBCL: meta-analysis and implications for clinical trial design. Leukemia & Lymphoma 63:12, pages 2816-2831.
Read now
Read now
François Allioux, Damaj Gandhi, Jean-Pierre Vilque, Cathy Nganoa, Anne-Claire Gac, Nicolas Aide & Charline Lasnon. (2021) End-of-treatment 18F-FDG PET/CT in diffuse large B cell lymphoma patients: ΔSUV outperforms Deauville score. Leukemia & Lymphoma 62:12, pages 2890-2898.
Read now
Read now
Long Qian, Miaoming Yan, Wei Zhang, Daobin Zhou, Yan Zhang, Li Huo, Yaping Luo, Yingqiang Zhang & Shaoxuan Hu. (2020) Prognostic value of interim 18F-FDG PET/CT in T-cell lymphomas. Leukemia & Lymphoma 61:4, pages 927-933.
Read now
Read now
Karen Juul Mylam, Lale Kostakoglu, Martin Hutchings, Morton Coleman, Dominick Lamonica, Myron S. Czuczman, Louis F. Diehl, Anne L. Nielsen, Paw Jensen, Annika Loft, Helle W. Hendel, Victor Iyer, Sirpa Leppä, Sirkku Jyrkkiö, Harald Holte, Mikael Eriksson, Dorte Gillstrøm, Per B. Hansen, Marko Seppänen, Karin Hjorthaug, Peter de Nully Brown & Lars M. Pedersen. (2015) 18F-fluorodeoxyglucose-positron emission tomography/computed tomography after one cycle of chemotherapy in patients with diffuse large B-cell lymphoma: results of a Nordic/US intergroup study. Leukemia & Lymphoma 56:7, pages 2005-2012.
Read now
Read now
Mohamed Touati, Manuela Delage-Corre, Jacques Monteil, Julie Abraham, Stéphane Moreau, Liliane Remenieras, Marie-Pierre Gourin, Nataliya Dmytruk, Agnès Olivrie, Pascal Turlure, Stéphane Girault, François Labrousse, Pierre-Marie Preux, Arnaud Jaccard & Dominique Bordessoule. (2015) CD68-positive tumor-associated macrophages predict unfavorable treatment outcomes in classical Hodgkin lymphoma in correlation with interim fluorodeoxyglucose-positron emission tomography assessment. Leukemia & Lymphoma 56:2, pages 332-341.
Read now
Read now
Theodoros P. Vassilakopoulos, Gerassimos A. Pangalis & Aaron Polliack. (2015) A “PET” topic in primary mediastinal large B-cell lymphoma: positive or negative, and how to handle it in the end. Leukemia & Lymphoma 56:1, pages 3-5.
Read now
Read now
Julia Chalaye, Alain Luciani, Catalina Enache, Pauline Beaussart, Catherine Lhermite, Eva Evangelista, Myriam Sasanelli, Violaine Safar, Michel Meignan, Corinne Haioun, Alain Rahmouni & Emmanuel Itti. (2014) Clinical impact of contrast-enhanced computed tomography combined with low-dose 18F-fluorodeoxyglucose positron emission tomography/computed tomography on routine lymphoma patient management. Leukemia & Lymphoma 55:12, pages 2887-2892.
Read now
Read now
Douglas A. Stewart, Reinhard Kloiber, Carolyn Owen, Nizar J. Bahlis, Peter Duggan, Adnan Mansoor & Isabelle Bence-Bruckler. (2014) Results of a prospective phase II trial evaluating interim positron emission tomography-guided high dose therapy for poor prognosis diffuse large B-cell lymphoma. Leukemia & Lymphoma 55:9, pages 2064-2070.
Read now
Read now
Michel Meignan. (2014) Reporting interim positron emission tomography in diffuse large B-cell lymphoma: the Zeno’s paradox. Leukemia & Lymphoma 55:4, pages 730-732.
Read now
Read now
Deniz Kahraman, Sebastian Theurich, Achim Rothe, Georg Kuhnert, Stephanie Sasse, Christoph Scheid, Markus Dietlein, Alexander Drzezga, Michael von Bergwelt-Baildon & Carsten Kobe. (2014) 18-Fluorodeoxyglucose positron emission tomography/computed tomography for assessment of response to brentuximab vedotin treatment in relapsed and refractory Hodgkin lymphoma. Leukemia & Lymphoma 55:4, pages 811-816.
Read now
Read now
Carla Casulo, Heiko Schöder, John Feeney, Remy Lim, Jocelyn Maragulia, Andrew D. Zelenetz & Steven Horwitz. (2013) 18F-fluorodeoxyglucose positron emission tomography in the staging and prognosis of T cell lymphoma. Leukemia & Lymphoma 54:10, pages 2163-2167.
Read now
Read now
Articles from other publishers (108)
Emmanuel Itti, Paul Blanc-Durand, Alina Berriolo-Riedinger, Salim Kanoun, Françoise Kraeber-Bodéré, Michel Meignan, Elodie Gat, Steven Le Gouill, René-Olivier Casasnovas & Caroline Bodet-Milin. (2023)
Validation of the ΔSUV
max
for Interim PET Interpretation in Diffuse Large B-Cell Lymphoma on the Basis of the GAINED Clinical Trial
. Journal of Nuclear Medicine 64:11, pages 1706-1711.
Crossref
Crossref
Yago Nieto, Pinaki Banerjee, Indresh Kaur, Kun Hee Kim, Dexing Fang, Peter F Thall, Lori Griffin, Melissa Barnett, Rafet Basar, Chitra Hosing, Jeremy Ramdial, Samer Srour, May Daher, David Marin, Xianli Jiang, Ken Chen, Richard Champlin, Elizabeth J Shpall & Katayoun Rezvani. (2023) EX VIVO-EXPANDED CORD BLOOD NK CELLS COMBINED WITH RITUXIMAB AND HIGH-DOSE CHEMOTHERAPY AND AUTOLOGOUS SCT FOR B-NHL. Transplantation and Cellular Therapy.
Crossref
Crossref
Yu Ohashi, Kiyoto Shiga, Katsunori Katagiri, Daisuke Saito, Shin‐ichi Oikawa, Kodai Tsuchida, Jun Miyaguchi, Takahiro Kusaka & Hiroyuki Yamada. (2023)
A case of complete remission of
H
odgkin lymphoma confirmed histopathologically by neck dissection
. Cancer Reports 6:8.
Crossref
Crossref
Francesca Tutino, Elisabetta Giovannini, Silvia Chiola, Giampiero Giovacchini & Andrea Ciarmiello. (2023) Assessment of Response to Immunotherapy in Patients with Hodgkin Lymphoma: Towards Quantifying Changes in Tumor Burden Using FDG-PET/CT. Journal of Clinical Medicine 12:10, pages 3498.
Crossref
Crossref
Lucia Zanoni, Davide Bezzi, Cristina Nanni, Andrea Paccagnella, Arianna Farina, Alessandro Broccoli, Beatrice Casadei, Pier Luigi Zinzani & Stefano Fanti. (2023) PET/CT in Non-Hodgkin Lymphoma: An Update. Seminars in Nuclear Medicine 53:3, pages 320-351.
Crossref
Crossref
Laure Michaud, Kurt Bantilan, Audrey Mauguen, Craig H. Moskowitz, Andrew D. Zelenetz & Heiko Schöder. (2023)
Prognostic Value of
18
F-FDG PET/CT in Diffuse Large B-Cell Lymphoma Treated with a Risk-Adapted Immunochemotherapy Regimen
. Journal of Nuclear Medicine 64:4, pages 536-541.
Crossref
Crossref
Sara Duarte, Adriana Roque, Tiago Saraiva, Carolina Afonso, Bárbara Almeida Marques, Carla Barros Lima, Dulcelena Neves, Ana Catarina Lai, Gracinda Costa, Augusta Cipriano, Catarina Geraldes, Lenka Ruzickova, José Pedro Carda & Marília Gomes. (2023) Interim FDG18-PET SUVmax Variation Adds Prognostic Value to Deauville 5-Point Scale in the Identification of Patients with Ultra-High-Risk Diffuse Large B Cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 23:2, pages e107-e116.
Crossref
Crossref
Cong Li, Haifeng Yu, Xi Chen, Shuiyun Han, Shuailing Peng, Tao Lei & Haiyan Yang. (2022) The Prognostic Utility of 18F-Fluorodeoxyglucose Positron Emission Tomography-Computed Tomography-Based Analyses of Metabolic Response Rates in Newly Diagnosed Diffuse Large B Cell Lymphoma Patients. Frontiers in Oncology 12.
Crossref
Crossref
Steven M. HorwitzStephen AnsellWeiyun Z. AiJeffrey BarnesStefan K. BartaJonathan BrammerMark W. ClemensAhmet DoganFrancine FossPaola GhioneAaron M. GoodmanJoan GuitartAhmad HalwaniBradley M. HaverkosRichard T. HoppeEric JacobsenDeepa JagadeeshAllison JonesAvyakta KallamYoun H. KimKiran KumarNeha Mehta-ShahElise A. OlsenSaurabh A. RajguruSima RozatiJonathan SaidAaron ShaverLauren SheaMichi M. ShinoharaLubomir SokolCarlos Torres-CabalaRyan WilcoxPeggy WuJasmine Zain, Mary DwyerHema Sundar. (2022) T-Cell Lymphomas, Version 2.2022, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 20:3, pages 285-308.
Crossref
Crossref
Ying-He Li, Yu-Mo Zhao, Yong-Luo Jiang, Si Tang, Mei-Ting Chen, Zi-Zheng Xiao, Wei Fan, Ying-Ying Hu & Xu Zhang. (2021) The prognostic value of end-of-treatment FDG-PET/CT in diffuse large B cell lymphoma: comparison of visual Deauville criteria and a lesion-to-liver SUVmax ratio-based evaluation system. European Journal of Nuclear Medicine and Molecular Imaging 49:4, pages 1311-1321.
Crossref
Crossref
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2020. Nuclear Oncology. Nuclear Oncology
1
45
.
Nicola M. Hughes, Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2022. Nuclear Oncology. Nuclear Oncology
431
474
.
Kimiteru Ito, Somali Gavane, Laure Michaud, Heiko Schöder, Vijay Yerubaudi, Christopher G. Sakellis, Annick D. Van den Abbeele, Heather A. Jacene, S. Al Shammari & F. Fraioli. 2022. Nuclear Oncology. Nuclear Oncology
1777
1792
.
Yafei Zhang, Guangfa Wang, Xin Zhao, Yongxian Hu, Elaine Tan Su Yin, Donghe Chen, Huatao Wang & Kui Zhao. (2021) The role of pre-treatment and mid-treatment 18F-FDG PET/CT imaging in evaluating prognosis of peripheral T-cell lymphoma-not otherwise specified (PTCL-NOS). BMC Medical Imaging 21:1.
Crossref
Crossref
Nawal Faiez AlShehry, Raja Shanker, Syed Ziauddin Ahmed Zaidi, Fahad AlGhmlas, Ibraheem Hussein Motabi, Shahid Iqbal, Ahmad Ali Butt, Hassan AlShehri, Imran Khan Tailor, Syed Yasir Altaf, Mubarak AlGhamdi, Mohammed Marie, Mansour AlFayez, Kamal Al Zahrani, Mohammed Dwaimah, Tahani Al-Halouli, Wafaa Al-Shakweer, Maied Zaher AlShehery, Abdul Rehman Zia Zaidi, Atta Munawar Gill, Belal Mohammed Albtoosh & Musab Ahmed. (2021) Role of 18F-Fluorodeoxyglucose–Positron Emission Tomography/Computed Tomography Imaging in the Prediction of Prognosis in Patients With Indolent Lymphoma: Prospective Study. JMIR Formative Research 5:11, pages e24936.
Crossref
Crossref
Gaetano Paone, Mariana Raditchkova-Sarnelli, Teresa Ruberto-Macchi, Marco Cuzzocrea, Emanuele Zucca, Luca Ceriani & Luca Giovanella. (2021) Limited benefit of additional contrast-enhanced CT to end-of-treatment PET/CT evaluation in patients with follicular lymphoma. Scientific Reports 11:1.
Crossref
Crossref
S. Zafar, R.K. Sharma, J. Cunningham, P. Mahalingam, A.D. Attygalle, N. Khan, D. Cunningham, D. El-Sharkawi, S. Iyengar & B. Sharma. (2021) Current and future best practice in imaging, staging, and response assessment for Non-Hodgkin's lymphomas: the Specialist Integrated Haematological Malignancy Imaging Reporting (SIHMIR) paradigm shift. Clinical Radiology 76:5, pages 391.e1-391.e18.
Crossref
Crossref
Steven Le Gouill, Hervé GhesquièresLucie Oberic, Franck Morschhauser, Hervé TillyVincent RibragThierry LamyCatherine ThieblemontHervé MaisonneuveRémy GressinKrimo BouhabdallahCorinne HaiounGandhi Damaj, Luc ForneckerRéda BouhabdallahPierre FeugierDavid Sibon, Guillaume Cartron, Christophe BonnetMarc AndréLoic ChartierPhilippe RuminyFrançoise Kraeber-Bodéré, Caroline Bodet-Milin, Alina Berriolo-Riedinger, Josette BrièreJean-Philippe Jais, Thierry Jo Molina, Emmanuel Itti & René-Olivier Casasnovas. (2021) Obinutuzumab vs rituximab for advanced DLBCL: a PET-guided and randomized phase 3 study by LYSA. Blood 137:17, pages 2307-2320.
Crossref
Crossref
Charles Mesguich, Cyrille Hulin, Valerie Latrabe, Axelle Lascaux, Laurence Bordenave, Elif Hindié & Gerald Marit. (2020) Prospective comparison of 18-FDG PET/CT and whole-body diffusion-weighted MRI in the assessment of multiple myeloma. Annals of Hematology 99:12, pages 2869-2880.
Crossref
Crossref
Tamás Györke, Robert Carr, Juliano J. Cerci, Claudio Meneghetti, Francisca Redondo, Monica Celli, Charity Gorospe, Chirayu U. Auewarakul, Linda Jorgov, Diana Paez & Stefano Fanti. (2020)
Combined Visual and Semiquantitative Evaluation Improves Outcome Prediction by Early Midtreatment
18
F-FDG PET in Diffuse Large B-Cell Lymphoma
. Journal of Nuclear Medicine 61:7, pages 999-1005.
Crossref
Crossref
Richard T. HoppeRanjana H. AdvaniWeiyun Z. AiRichard F. AmbinderPhilippe ArmandCeleste M. BelloCecil M. BenitezPhilip J. BiermanKirsten M. BoughanBouthaina DabajaLeo I. GordonFrancisco J. Hernandez-IlizaliturriAlex F. HerreraEphraim P. HochbergJiayi HuangPatrick B. JohnstonMark S. KaminskiVaishalee P. KenkreNadia KhanRyan C. LynchKami MaddocksJonathan McConathyMatthew McKinneyMonika MetzgerDavid MorganCarolyn MulroneyRachel RabinovitchKaren C. RosenspireStuart SeropianRanda TaoJane N. WinterJoachim Yahalom, Jennifer L. BurnsNdiya Ogba. (2020) Hodgkin Lymphoma, Version 2.2020, NCCN Clinical Practice Guidelines in Oncology. Journal of the National Comprehensive Cancer Network 18:6, pages 755-781.
Crossref
Crossref
Young‐Woo Jeon, Joo‐Hyun O, Kyung‐Sin Park, Gi June Min, Sung‐Soo Park, Jae‐Ho Yoon, Ki‐Seong Eom, Chang‐Ki Min & Seok‐Goo Cho. (2019) Prognostic impact of interim positron emission tomography in mantle cell lymphoma patients treated with frontline R‐CHOP. British Journal of Haematology 188:6, pages 860-871.
Crossref
Crossref
Rafet Eren, Cihan Gündoğan, Ceyda Aslan, Alper Koç, Mehmet Hilmi Doğu, Şermin Altındal, Osman Yokuş, Elif Suyanı & Tevfik Fikret Çermik. (2020) Evaluation of the Reliability of Interim PET/CT in the Hodgkin Lymphoma. Current Medical Imaging Formerly Current Medical Imaging Reviews 16:1, pages 59-64.
Crossref
Crossref
Rahul V. Parghane & Sandip Basu. (2020) PET/Computed Tomography in Treatment Response Assessment in Cancer. PET Clinics 15:1, pages 101-123.
Crossref
Crossref
Katherine A. Zukotynski, Phillip H. Kuo, Chun K. Kim & Rathan M. Subramaniam. 2020. Therapy Response Imaging in Oncology. Therapy Response Imaging in Oncology
255
272
.
Craig S. Sauter, Brigitte Senechal, Isabelle Rivière, Ai Ni, Yvette Bernal, Xiuyan Wang, Terence Purdon, Malloury Hall, Ashvin N. Singh, Victoria Z. Szenes, Sarah Yoo, Ahmet Dogan, Yongzeng Wang, Craig H. Moskowitz, Sergio Giralt, Matthew J. Matasar, Miguel-Angel Perales, Kevin J. Curran, Jae Park, Michel Sadelain & Renier J. Brentjens. (2019) CD19 CAR T cells following autologous transplantation in poor-risk relapsed and refractory B-cell non-Hodgkin lymphoma. Blood 134:7, pages 626-635.
Crossref
Crossref
Mathieu N. Toledano, Pierre Vera, Hervé Tilly, Fabrice Jardin & Stéphanie Becker. (2019) Comparison of therapeutic evaluation criteria in FDG-PET/CT in patients with diffuse large-cell B-cell lymphoma: Prognostic impact of tumor/liver ratio. PLOS ONE 14:2, pages e0211649.
Crossref
Crossref
C. Bodet-Milin, E. Itti & P.Y. Salaün. (2019) Lymphomes. Médecine Nucléaire 43:1, pages 150-160.
Crossref
Crossref
Ruimin Wang, Baixuan Xu, Changbin Liu, Zhiwei Guan, Jinming Zhang, Fei Li, Lu Sun & Haiyan Zhu. (2018) Prognostic value of interim fluorodeoxyglucose and fluorothymidine PET/CT in diffuse large B-cell lymphoma. The British Journal of Radiology 91:1091, pages 20180240.
Crossref
Crossref
Clément Bailly, Thomas Carlier, Bastien Jamet, Thomas Eugene, Cyrille Touzeau, Michel Attal, Cyrille Hulin, Thierry Facon, Xavier Leleu, Aurore Perrot, Laurent Garderet, Margaret Macro, Denis Caillot, Philippe Moreau, Françoise Kraeber-Bodéré & Caroline Bodet-Milin. (2018) Interim PET Analysis in First-Line Therapy of Multiple Myeloma: Prognostic Value of ΔSUVmax in the FDG-Avid Patients of the IMAJEM Study. Clinical Cancer Research 24:21, pages 5219-5224.
Crossref
Crossref
Thomas W. Georgi, Regine Kluge, Lars Kurch, Lidia Chavdarova, Dirk Hasenclever, Dietrich Stoevesandt, Tanja Pelz, Judith Landman-Parker, W. Hamish Wallace, Jonas Karlen, Ana Fernández-Teijeiro, Michaela Cepelova, Alexander Fosså, Walentyna Balwierz, Andishe Attarbaschi, Roland A. Ammann, Jane Pears, Andrea Hraskova, Anne Uyttebroeck, Auke Beishuizen, Karin Dieckmann, Thierry Leblanc, Stephen Daw, Julia Baumann, Dieter Körholz, Osama Sabri & Christine Mauz-Körholz. (2018)
18
F-FDG PET Response of Skeletal (Bone Marrow and Bone) Involvement After Induction Chemotherapy in Pediatric Hodgkin Lymphoma: Are Specific Response Criteria Required?
. Journal of Nuclear Medicine 59:10, pages 1524-1530.
Crossref
Crossref
Hua-Jay J. Cherng, Rachel Lynn Sargent, Sunita Dwivedy Nasta, Jakub Svoboda, Stephen J. Schuster, Anthony R. Mato, April Schrank-Hacker, Jennifer J.D. Morrissette & Daniel J. Landsburg. (2018) Interim PET/CT Result Is Not Predictive of Survival in Patients With MYC-rearranged Non–Burkitt Aggressive B-cell Lymphoma. Clinical Lymphoma Myeloma and Leukemia 18:10, pages 673-678.
Crossref
Crossref
Seo-Yeon Ahn, Seong Young Kwon, Sung-Hoon Jung, Jae-Sook Ahn, Su Woong Yoo, Jung-Joon Min, Hee-Seung Bom, So Yeon Ki, Hyeoung-Joon Kim, Je-Jung Lee, Sang Yun Song & Deok-Hwan Yang. (2018) Prognostic Significance of Interim 11C-Methionine PET/CT in Primary Central Nervous System Lymphoma. Clinical Nuclear Medicine 43:8, pages e259-e264.
Crossref
Crossref
Alessandra Romano, Nunziatina Laura Parrinello, Calogero Vetro, Annalisa Chiarenza, Claudio Cerchione, Massimo Ippolito, Giuseppe Alberto Palumbo & Francesco Di Raimondo. (2018) Prognostic meaning of neutrophil to lymphocyte ratio (NLR) and lymphocyte to monocyte ration (LMR) in newly diagnosed Hodgkin lymphoma patients treated upfront with a PET-2 based strategy. Annals of Hematology 97:6, pages 1009-1018.
Crossref
Crossref
Alessia Bari, Luigi Marcheselli, Raffaella Marcheselli, Samantha Pozzi, Maria Christina Cox, Cinzia Baldessari, Paola Ferri, Paolo Gobbi, Luca Baldini, Tamar Tadmor, Pellegrino Musto, Massimo Federico & Stefano Sacchi. (2016)
Absolute monocyte count at diagnosis could improve the prognostic role of early
FDG
‐
PET
in classical Hodgkin lymphoma patients
. British Journal of Haematology 180:4, pages 600-602.
Crossref
Crossref
Chong Jiang, Jie Liu, Li Li, Russell O. Kosik, Minggang Su, Liqun Zou & Rong Tian. (2017) Predictive approaches for post-therapy PET/CT in patients with extranodal natural killer/T-cell lymphoma. Nuclear Medicine Communications 38:11, pages 937-947.
Crossref
Crossref
Joel Cunningham, Sunil Iyengar & Bhupinder Sharma. (2017) Evolution of lymphoma staging and response evaluation: current limitations and future directions. Nature Reviews Clinical Oncology 14:10, pages 631-645.
Crossref
Crossref
M. del Puig Cózar-Santiago, J.R. García-Garzón, M. Moragas-Freixa, M. Soler-Peter, P. Bassa Massanas, M. Sánchez-Delgado, R. Sanchez-Jurado, J.E. Aguilar-Barrios, R. Sanz-Llorens & J. Ferrer-Rebolleda. (2017) Optimization of metabolic criteria in the prognostic assessment of patients with lymphoma. A multicenter study. Revista Española de Medicina Nuclear e Imagen Molecular (English Edition) 36:5, pages 304-311.
Crossref
Crossref
M. del Puig Cózar-Santiago, J.R. García-Garzón, M. Moragas-Freixa, M. Soler-Peter, P. Bassa Massanas, M. Sánchez-Delgado, R. Sanchez-Jurado, J.E. Aguilar-Barrios, R. Sanz-Llorens & J. Ferrer-Rebolleda. (2017) Optimización de los criterios metabólicos en la valoración pronóstica de los pacientes con linfoma. Estudio multicéntrico. Revista Española de Medicina Nuclear e Imagen Molecular 36:5, pages 304-311.
Crossref
Crossref
Senthilkumar Kalimuthu, Ju Hye Jeong, Ji Min Oh & Byeong-Cheol Ahn. (2017) Drug Discovery by Molecular Imaging and Monitoring Therapy Response in Lymphoma. International Journal of Molecular Sciences 18:8, pages 1639.
Crossref
Crossref
Steven Le GouillRené-Olivier Casasnovas. (2017) Interim PET-driven strategy in de novo diffuse large B-cell lymphoma: do we trust the driver?. Blood 129:23, pages 3059-3070.
Crossref
Crossref
Caitlin Costello, Loren K. Mell & Parag Sanghvi. 2017. Clinical Radiation Oncology. Clinical Radiation Oncology
775
804
.
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2017. Nuclear Oncology. Nuclear Oncology
353
393
.
Maital Bolshinsky & Chadi Nabhan. (2016) Interim PET Scans in Diffuse Large B-Cell Lymphoma: Is It Ready for Prime Time?. Clinical Lymphoma Myeloma and Leukemia 16:12, pages 655-661.
Crossref
Crossref
Paolo F. Caimi, Brian T. Hill, Eric D. Hsi & Mitchell R. Smith. (2016) Clinical approach to diffuse large B cell lymphoma. Blood Reviews 30:6, pages 477-491.
Crossref
Crossref
Sofie Bæk Christlieb, Casper Nørgaard Strandholdt, Birgitte Brinkmann Olsen, Karen Juul Mylam, Thomas Stauffer Larsen, Anne Lerberg Nielsen, Max Rohde, Oke Gerke, Karen Ege Olsen, Michael Boe Møller, Bjarne Winther Kristensen, Niels Abildgaard, Abass Alavi & Poul Flemming Høilund-Carlsen. (2016) Dual time-point FDG PET/CT and FDG uptake and related enzymes in lymphadenopathies: preliminary results. European Journal of Nuclear Medicine and Molecular Imaging 43:10, pages 1824-1836.
Crossref
Crossref
Yago Nieto, Benigno C. Valdez, Peter F. Thall, Roy B. Jones, Wei Wei, Alan Myers, Chitra Hosing, Sairah Ahmed, Uday Popat, Elizabeth J. Shpall, Muzaffar Qazilbash, Alison Gulbis, Paolo Anderlini, Nina Shah, Qaiser Bashir, Amin Alousi, Yasuhiro Oki, Michelle Fanale, Bouthaina Dabaja, Chelsea Pinnix, Richard Champlin & Borje S. Andersson. (2016) Double epigenetic modulation of high‐dose chemotherapy with azacitidine and vorinostat for patients with refractory or poor‐risk relapsed lymphoma. Cancer 122:17, pages 2680-2688.
Crossref
Crossref
Piero Farruggia, Giuseppe Puccio, Alessandra Sala, Alessandra Todesco, Monica Terenziani, Rosamaria Mura, Salvatore D'Amico, Tommaso Casini, Clara Mosa, Marta Pillon, Maria Paola Boaro, Gaetano Bottigliero, Roberta Burnelli, Caterina Consarino, Fausto Fedeli, Maurizio Mascarin, Katia Perruccio, Elisabetta Schiavello, Angela Trizzino, Umberto Ficola, Alberto Garaventa & Mario Rossello. (2016) Abdomen/pelvis computed tomography in staging of pediatric Hodgkin Lymphoma: is it always necessary?. Cancer Medicine 5:9, pages 2359-2367.
Crossref
Crossref
Andreas Engert & John Raemaekers. (2016) Treatment of early-stage Hodgkin lymphoma. Seminars in Hematology 53:3, pages 165-170.
Crossref
Crossref
F. de Galiza Barbosa, G. Delso, E.E.G.W. ter Voert, M.W. Huellner, K. Herrmann & P. Veit-Haibach. (2016) Multi-technique hybrid imaging in PET/CT and PET/MR: what does the future hold?. Clinical Radiology 71:7, pages 660-672.
Crossref
Crossref
Mateen C. Moghbel, Lale Kostakoglu, Katherine Zukotynski, Delphine L. Chen, Helen Nadel, Ryan Niederkohr & Erik Mittra. (2016) Response Assessment Criteria and Their Applications in Lymphoma: Part 1. Journal of Nuclear Medicine 57:6, pages 928-935.
Crossref
Crossref
S H Lim, S H Hyun, H S Kim, J Y Lee, K H Yoo, K S Jung, H-N Song, J Cho, S Park, Y H Ko, S J Kim, J Y Choi & W S Kim. (2016) Prognostic relevance of pretransplant Deauville score on PET-CT and presence of EBV DNA in patients who underwent autologous stem cell transplantation for ENKTL. Bone Marrow Transplantation 51:6, pages 807-812.
Crossref
Crossref
Matthew Koshy, Andrew Fairchild, Christina H. Son & Usama Mahmood. (2016) Improved survival time trends in Hodgkin's lymphoma. Cancer Medicine 5:6, pages 997-1003.
Crossref
Crossref
Michael Coyle, Lale Kostakoglu & Andrew M. Evens. (2016) The evolving role of response-adapted PET imaging in Hodgkin lymphoma. Therapeutic Advances in Hematology 7:2, pages 108-125.
Crossref
Crossref
S.F. Barrington, P. Fosse, N. Withofs, E. Itti, R. Hustinx, O.-F. Couturier & M. Meignan. (2016) Recommendations to stage and assess the response to therapy of lymphomas with [18F]FDG-PET-CT. Médecine Nucléaire 40:1, pages 55-64.
Crossref
Crossref
Kenneth B. Roberts, Kara M. Kelly & Louis S. Constine. 2016. Clinical Radiation Oncology. Clinical Radiation Oncology
1464
1485.e5
.
Andrea Gallamini, Anna Borra & Colette Zwarthoed. 2016. PET Scan in Hodgkin Lymphoma. PET Scan in Hodgkin Lymphoma
31
64
.
Theodoros P. Vassilakopoulos, Vassilios K. Prassopoulos, Phoivi Rondogianni, Sofia N. Chatziioannou, Vasileios I. Telonis & Effimia P. Vrakidou. 2016. PET/CT in Lymphomas. PET/CT in Lymphomas
111
171
.
Heather A. Jacene, Sree Harsha Tirumani & Richard L. Wahl. 2016. Nuclear Oncology. Nuclear Oncology
1
42
.
Kara M. Kelly. (2015) Hodgkin lymphoma in children and adolescents: improving the therapeutic index. Hematology 2015:1, pages 514-521.
Crossref
Crossref
Sung-Hoon Jung, Jae-Sook Ahn, Yeo-Kyeoung Kim, Sun-Seog Kweon, Jung-Joon Min, Hee-Seung Bom, Hyeoung-Joon Kim, Yee Soo Chae, Joon Ho Moon, Sang Kyun Sohn, Sang Woo Lee, Byung Hyun Byun, Young Rok Do, Je-Jung Lee & Deok-Hwan Yang. (2015) Prognostic significance of interim PET/CT based on visual, SUV-based, and MTV-based assessment in the treatment of peripheral T-cell lymphoma. BMC Cancer 15:1.
Crossref
Crossref
Kara M. Kelly. (2015) Hodgkin lymphoma in children and adolescents: improving the therapeutic index. Blood 126:22, pages 2452-2458.
Crossref
Crossref
Christine Mauz-KörholzMonika L. MetzgerKara M. KellyCindy L. SchwartzMauricio E. CastellanosKarin DieckmannRegine KlugeDieter Körholz. (2015) Pediatric Hodgkin Lymphoma. Journal of Clinical Oncology 33:27, pages 2975-2985.
Crossref
Crossref
P. Berger, I. Vaartjes, A. Scholtens, F.L. Moll, G.J. De Borst, B. De Keizer, M.L. Bots & J.D. Blankensteijn. (2015) Differential FDG-PET Uptake Patterns in Uninfected and Infected Central Prosthetic Vascular Grafts. European Journal of Vascular and Endovascular Surgery 50:3, pages 376-383.
Crossref
Crossref
Parastoo Bahrami Dahi, Gabriela Soriano Hobbs & Miguel‐Angel Perales. 2015. Clinical Guide to Transplantation in Lymphoma. Clinical Guide to Transplantation in Lymphoma
23
29
.
P. Ganesan, R. Rajendranath, K. Kannan, V. Radhakrishnan, T.S. Ganesan, K. Udupa, K.M. Lakshmipathy, V. Mahajan, S. Sundersingh, S. Rajaraman, R. Krishnakumar & T.G. Sagar. (2015) Phase II study of interim PET–CT-guided response-adapted therapy in advanced Hodgkin's lymphoma. Annals of Oncology 26:6, pages 1170-1174.
Crossref
Crossref
Theodoros P. Vassilakopoulos, Vassilios Prassopoulos, Phoivi Rondogianni, Sofia Chatziioannou, Kostas Konstantopoulos & Maria K. Angelopoulou. (2015) Role of FDG-PET/CT in staging and first-line treatment of Hodgkin and aggressive B-cell lymphomas. memo - Magazine of European Medical Oncology 8:2, pages 105-114.
Crossref
Crossref
Luigi Rigacci, Benedetta Puccini, Pier Luigi Zinzani, Alberto Biggi, Antonio Castagnoli, Francesco Merli, Monica Balzarotti, Caterina Stelitano, Michele Spina, Umberto Vitolo, Vittorio Stefoni, Alessandro Levis, Manuel Gotti, Sancetta Rosaria, Stefani Piero Maria, Alberto Bosi & Andrea Gallamini. (2015) The prognostic value of positron emission tomography performed after two courses (INTERIM-PET) of standard therapy on treatment outcome in early stage Hodgkin lymphoma: A multicentric study by the fondazione italiana linfomi (FIL). American Journal of Hematology 90:6, pages 499-503.
Crossref
Crossref
S. Horwitz, B. Coiffier, F. Foss, H.M. Prince, L. Sokol, M. Greenwood, D. Caballero, F. Morschhauser, L. Pinter-Brown, S.P. Iyer, A. Shustov, J. Nichols, J. Balser, B. Balser & B. Pro. (2015) Utility of18fluoro-deoxyglucose positron emission tomography for prognosis and response assessments in a phase 2 study of romidepsin in patients with relapsed or refractory peripheral T-cell lymphoma. Annals of Oncology 26:4, pages 774-779.
Crossref
Crossref
Emmanuel Bachy & Gilles Salles. (2015) Treatment Approach to Newly Diagnosed Diffuse Large B-Cell Lymphoma. Seminars in Hematology 52:2, pages 107-118.
Crossref
Crossref
Ben R. Saleem, Paul Berger, Ilonca Vaartjes, Bart de Keizer, Evert-Jan P.A. Vonken, Riemer H.J.A. Slart, Gert Jan de Borst & Clark J. Zeebregts. (2015) Modest utility of quantitative measures in 18 F-fluorodeoxyglucose positron emission tomography scanning for the diagnosis of aortic prosthetic graft infection. Journal of Vascular Surgery 61:4, pages 965-971.
Crossref
Crossref
Sree Harsha Tirumani, Ann S. LaCasce & Heather A. Jacene. (2015) Role of 2-Deoxy-2-[18F]-fluoro-d-glucose-PET/Computed Tomography in Lymphoma. PET Clinics 10:2, pages 207-225.
Crossref
Crossref
Michel Meignan, Emmanuel Itti, Andrea Gallamini & Anas Younes. (2015) FDG PET/CT imaging as a biomarker in lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 42:4, pages 623-633.
Crossref
Crossref
Thomas Carlier & Clément Bailly. (2015) State-Of-The-Art and Recent Advances in Quantification for Therapeutic Follow-Up in Oncology Using PET. Frontiers in Medicine 2.
Crossref
Crossref
Sandip Basu, Rakesh Kumar & Rohit Ranade. (2015) Assessment of Treatment Response Using PET. PET Clinics 10:1, pages 9-26.
Crossref
Crossref
Vasiliki Leventaki, Joseph D. Khoury & Stephan D. Voss. 2015. Pediatric Malignancies: Pathology and Imaging. Pediatric Malignancies: Pathology and Imaging
103
149
.
Andrew M. Evens & Lale Kostakoglu. (2014) The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Hematology 2014:1, pages 135-143.
Crossref
Crossref
Michel Meignan. (2014) FDG-PET in lymphoma. Cancer Imaging 14:S1.
Crossref
Crossref
Christophe Fruchart, Hervé Tilly, Franck Morschhauser, Hervé Ghesquières, Marie Bouteloup, Christophe Fermé, Eric Van Den Neste, Dominique Bordessoule, Reda Bouabdallah, Alain Delmer, René Olivier Casasnovas, Loïc Ysebaert, Renaud Ciappuccini, Josette Briere & Christian Gisselbrecht. (2014) Upfront Consolidation Combining Yttrium-90 Ibritumomab Tiuxetan and High-Dose Therapy with Stem Cell Transplantation in Poor-Risk Patients with Diffuse Large B Cell Lymphoma. Biology of Blood and Marrow Transplantation 20:12, pages 1905-1911.
Crossref
Crossref
Andrew M. Evens & Lale Kostakoglu. (2014) The role of FDG-PET in defining prognosis of Hodgkin lymphoma for early-stage disease. Blood 124:23, pages 3356-3364.
Crossref
Crossref
Sandip Basu, Habib Zaidi, Ali Salavati, Søren Hess, Poul Flemming Høilund Carlsen & Abass Alavi. (2014) FDG PET/CT methodology for evaluation of treatment response in lymphoma: from “graded visual analysis” and “semiquantitative SUVmax” to global disease burden assessment. European Journal of Nuclear Medicine and Molecular Imaging 41:11, pages 2158-2160.
Crossref
Crossref
Karen Juul Mylam, Anne Lerberg Nielsen, Lars Møller Pedersen & Martin Hutchings. (2014) Fluorine-18-fluorodeoxyglucose Positron Emission Tomography in Diffuse Large B-cell Lymphoma. PET Clinics 9:4, pages 443-455.
Crossref
Crossref
Zhou Lu, Michael Lin, Paul Downe, Shanley Chong & Silvia Ling. (2014) The prognostic value of mid- and post-treatment [18F]fluorodeoxyglucose (FDG) positron emission tomography (PET) in indolent follicular lymphoma. Annals of Nuclear Medicine 28:8, pages 805-811.
Crossref
Crossref
Pek-Lan Khong, Bingsheng Huang, Elaine Yuen Phin Lee, Winnie Kit Sum Chan & Yok-Lam Kwong. (2014)
Midtreatment
18
F-FDG PET/CT Scan for Early Response Assessment of SMILE Therapy in Natural Killer/T-Cell Lymphoma: A Prospective Study from a Single Center
. Journal of Nuclear Medicine 55:6, pages 911-916.
Crossref
Crossref
Ryan D. Gentzler, Andrew M. Evens, Alfred W. Rademaker, Bing B. Weitner, Bharat B. Mittal, Gary L. Dillehay, Adam M. Petrich, Jessica K. Altman, Olga Frankfurt, Daina Variakojis, Seema Singhal, Jayesh Mehta, Stephanie Williams, Lynne Kaminer, Leo I. Gordon & Jane N. Winter. (2014) F-18 FDG-PET predicts outcomes for patients receiving total lymphoid irradiation and autologous blood stem-cell transplantation for relapsed and refractory Hodgkin lymphoma. British Journal of Haematology 165:6, pages 793-800.
Crossref
Crossref
Bouthaina S. Dabaja, Kenneth Hess, Ferial Shihadeh, Donald A. Podoloff, L. Jeffrey Medeiros, Osama Mawlawi, Isidora Arzu, Yasuhiro Oki, Fredrick B. Hagemeister, Luis E. Fayad, Valerie K. Reed, Aziza Kedir, Christine F. Wogan & Alma Rodriguez. (2014) Positron Emission Tomography/Computed Tomography Findings During Therapy Predict Outcome in Patients With Diffuse Large B-Cell Lymphoma Treated With Chemotherapy Alone but Not in Those Who Receive Consolidation Radiation. International Journal of Radiation Oncology*Biology*Physics 89:2, pages 384-391.
Crossref
Crossref
Craig S. Sauter, Lauren Lechner, Michael Scordo, Junting Zheng, Sean M. Devlin, Stephen E. Fleming, Hugo Castro-Malaspina & Craig H. Moskowitz. (2014) Pretransplantation Fluorine-18-Deoxyglucose–Positron Emission Tomography Scan Lacks Prognostic Value in Chemosensitive B Cell Non-Hodgkin Lymphoma Patients Undergoing Nonmyeloablative Allogeneic Stem Cell Transplantation. Biology of Blood and Marrow Transplantation 20:6, pages 881-884.
Crossref
Crossref
P. Gordien, C. Morliere, L. Bordenave & E. Hindie. (2014) Variation de la captation hépatique de 18-FDG dans l’évaluation intermédiaire des lymphomes B diffus à grandes cellules en TEP/TDM. Médecine Nucléaire 38:2, pages 83-90.
Crossref
Crossref
Christelle Tychyj-Pinel, Fabien Ricard, Michael Fulham, Marion Fournier, Michel Meignan, Thierry Lamy, Pierre Vera, Gilles Salles & Judith Trotman. (2014) PET/CT assessment in follicular lymphoma using standardized criteria: central review in the PRIMA study. European Journal of Nuclear Medicine and Molecular Imaging 41:3, pages 408-415.
Crossref
Crossref
George P. Canellos, Saul A. Rosenberg, Jonathan W. Friedberg, T. Andrew Lister & Vincent T. DeVita. (2014) Treatment of Hodgkin Lymphoma: A 50-Year Perspective. Journal of Clinical Oncology 32:3, pages 163-168.
Crossref
Crossref
É. Herin, J. Chalaye, J.-L. Lagrange, K. Belhadj, É. De Kerviler, A. Luciani, A. Rahmouni & E. Itti. 2014. Imagerie Post-Thérapeutique en Oncologie. Imagerie Post-Thérapeutique en Oncologie
265
298
.
Theodoros P. Vassilakopoulos & Vassilios K. Prassopoulos. 2014. Imaging in Clinical Oncology. Imaging in Clinical Oncology
249
265
.
Michael Lin & Divesh Kumar. 2014. Functional Imaging in Oncology. Functional Imaging in Oncology
181
211
.
Frederick D. Grant. 2014. Pediatric Nuclear Medicine and Molecular Imaging. Pediatric Nuclear Medicine and Molecular Imaging
479
496
.
Trifon J. Spyridonidis, Panayota Matsouka, Argiris Symeonidis, Christos Savvopoulos, Pavlos J. Vassilakos & Dimitris J. Apostolopoulos. (2013) 99mTc Sestamibi as a Prognostic Factor of Response to First-Line Therapy and Outcome in Patients With Malignant Lymphoma. Clinical Nuclear Medicine 38:11, pages 847-854.
Crossref
Crossref
Andrea Riccardo Filippi, Cristina Piva, Francesca Giunta, Marilena Bellò, Annalisa Chiappella, Daniele Caracciolo, Michela Zotta, Anastasios Douroukas, Riccardo Ragona, Umberto Vitolo, Gianni Bisi & Umberto Ricardi. (2013) Radiation Therapy in Primary Mediastinal B-Cell Lymphoma With Positron Emission Tomography Positivity After Rituximab Chemotherapy. International Journal of Radiation Oncology*Biology*Physics 87:2, pages 311-316.
Crossref
Crossref
Ukihide Tateishi. (2013) PET/CT in malignant lymphoma: basic information, clinical application, and proposal. International Journal of Hematology 98:4, pages 398-405.
Crossref
Crossref
Martin Allen-Auerbach, Sven de Vos & Johannes Czernin. (2013) PET/Computed Tomography and Lymphoma. Radiologic Clinics of North America 51:5, pages 833-844.
Crossref
Crossref
Emmanuel Itti, Michel Meignan, Alina Berriolo-Riedinger, Alberto Biggi, Amanda F. Cashen, Pierre Véra, Hervé Tilly, Barry A. Siegel, Andrea Gallamini, René-Olivier Casasnovas & Corinne Haioun. (2013) An international confirmatory study of the prognostic value of early PET/CT in diffuse large B-cell lymphoma: comparison between Deauville criteria and ΔSUVmax. European Journal of Nuclear Medicine and Molecular Imaging 40:9, pages 1312-1320.
Crossref
Crossref
Raghava Kashyap, Eddie Lau, Anupkumar George, John F. Seymour, Stephen Lade, Rodney J. Hicks & Michael S. Hofman. (2013) High FDG activity in focal fat necrosis: a pitfall in interpretation of posttreatment PET/CT in patients with non-Hodgkin lymphoma. European Journal of Nuclear Medicine and Molecular Imaging 40:9, pages 1330-1336.
Crossref
Crossref
Shamzah ArafSilvia Montoto. (2013)
The use of interim
18
F-fluorodeoxyglucose PET to guide therapy in lymphoma
. Future Oncology 9:6, pages 807-815.
Crossref
Crossref
David Groheux, Marc Delord, Domenico Rubello, Patrick M. Colletti, Minh-Loan Nguyen & Elif Hindié. (2013) Variation of Liver SUV on 18FDG-PET/CT Studies in Women With Breast Cancer. Clinical Nuclear Medicine 38:6, pages 422-425.
Crossref
Crossref
Kara M. Kelly, David Hodgson, Burton Appel, Lu Chen, Peter D. Cole, Terzah Horton & Frank G. Keller. (2012) Children's Oncology Group's 2013 blueprint for research: Hodgkin lymphoma. Pediatric Blood & Cancer 60:6, pages 972-978.
Crossref
Crossref
C. Furth, A. S. Erdrich, I. G. Steffen, J. Ruf, M. Stiebler, D. Kahraman, C. Kobe, S. Schönberger, R. Grandt, P. Hundsdoerfer, K. Hauptmann, H. Amthauer & H. Hautzel. (2017) Interim PET response criteria in paediatric non-Hodgkin’s lymphoma. Nuklearmedizin 52:04, pages 15-20.
Crossref
Crossref
Andrea Gallamini & Lale Kostakoglu. (2012) Interim FDG-PET in Hodgkin lymphoma: a compass for a safe navigation in clinical trials?. Blood 120:25, pages 4913-4920.
Crossref
Crossref
Craig H. Moskowitz. (2012) Interim PET-CT in the management of diffuse large B-cell lymphoma. Hematology 2012:1, pages 397-401.
Crossref
Crossref
Sylvia Hartmann, Claudio Agostinelli, Jürgen Diener, Claudia Döring, Stefano Fanti, Pier Luigi Zinzani, Andrea Gallamini, Lothar Bergmann, Stefano Pileri & Martin-Leo Hansmann. (2012) GLUT1 expression patterns in different Hodgkin lymphoma subtypes and progressively transformed germinal centers. BMC Cancer 12:1.
Crossref
Crossref
Ronan Abgral, Pierre-Yves Le Roux, Nathalie Keromnes, Jean Rousset, Gérald Valette, Dominique Gouders, Cyril Leleu, Delphine Mollon, Emmanuel Nowak, Solène Querellou & Pierre-Yves Salaün. (2012) Early prediction of survival following induction chemotherapy with DCF (docetaxel, cisplatin, 5-fluorouracil) using FDG PET/CT imaging in patients with locally advanced head and neck squamous cell carcinoma. European Journal of Nuclear Medicine and Molecular Imaging 39:12, pages 1839-1847.
Crossref
Crossref